Consumer attitudes toward pharmaceutical direct-to-consumer advertising: An empirical study and the role of income

International Journal of Pharmaceutical and Healthcare Marketing

Volumn 2, Issue 2, 2008, Pages 117-133

  Joseph, Mathew ^a   Spake, Deborah F ^b   Finney, Zachary ^b  

^a ST MARY'S UNIVERSITY   (United States)

^b University of South Alabama   (United States)

Author keywords

Advertising effectiveness; Consumer behaviour; Demographics; Pharmaceutical products

Indexed keywords

EID: 84856233801     PISSN: 17506123     EISSN: None     Source Type: Journal    
DOI: 10.1108/17506120810887916     Document Type: Article

References (44)

1. Avron, J. (2003), "Advertising and prescription drugs: promotion, education, and the public's health" in Health Affairs, Vol. 22, No. 1, pp. 104-8.
2. Basara, L.R. (1996), "The impact of a direct-to-consumer prescription medication advertising campaign on new prescription volume" in Drug Information Journal, Vol. 30, No. 3, pp. 715-29.
3. Bell, R.A., Wilkes, M.S., Kravitz, R.L. (1999), "Advertisement-induced drug requests" in Journal of Family Practice, Vol. 48, No. 6, pp. 446-52.
4. Bell, R.A., Wilkes, M.S., Kravitz, R.L. (2000), "The educational value of prescription drug print advertising" in Journal of Family Practice, Vol. 49, No. 12, pp. 1092-8.
5. Calfee, J.E. (2002), "Public policy issues in direct-to-consumer advertising of prescription drugs" in Journal of Public Policy & Marketing, Vol. 21, No. 2, pp. 174-93.
6. Cardarelli, R., Licciardone, J.C., Taylor, L.G. (2006), "A cross-sectional evidence-based review of pharmaceutical promotional marketing brochures and their underlying studies: is what they tell us important and true?" in BMC Family Practice, Vol. 7, No. 13, pp. 1-6.
7. Coney, S. (2002), "Direct-to-consumer advertising of pharmaceuticals: a consumer perspective from New Zealand" in Journal of Public Policy & Marketing, Vol. 21, No. 2, pp. 213-23.
8. Davis, J.J. (2000), "Riskier than we think? The relationship between risk statement completeness and perceptions of direct to consumer advertised prescription drugs" in Journal of Health Communication, Vol. 5, No. 4, pp. 349-69.
9. DeNavas-Walt, C., Proctor, B.D., Lee, C.H. (2006), "US census bureau, current population reports, P60-231", Income, Poverty, and Health Insurance Coverage in the United States: 2005, US Government Printing Office, Washington, DC.
10. Friedman, M., Gould, J. (2007), "Physicians' attitudes toward direct-to-consumer prescription drug marketing" in Journal of Medical Marketing, Vol. 7, No. 1, pp. 33-44.
11. Handlin, A., Mosca, J.B., Forgione, D.A., Pitta, D. (2003), "DTC pharmaceutical advertising: the debate's not over" in Journal of Consumer Marketing, Vol. 20, No. 3, pp. 227-37.
12. Harker, M., Harker, D. (2007), "Direct-to-consumer advertising of prescription medicines: a systematic review of the evidence from the perspective of the consumer" in Journal of Medical Marketing, Vol. 7, No. 1, pp. 45-54.
13. Herzenstein, M., Misra, S., Posavac, S.S. (2004), "How consumers' attitudes toward direct-to-consumer advertising of prescription drugs influences ad effectiveness, and consumer and physician behavior" in Marketing Letters, Vol. 15, No. 4, pp. 201-12.
14. Hoek, J., Gendall, P. (2002), "Direct-to-consumer advertising down under: an alternative perspective and regulatory framework" in Journal of Public Policy & Marketing, Vol. 21, No. 2, pp. 202-12.
15. Hoek, J., Gendall, P., Calfee, J. (2004), "Direct-to-consumer advertising of prescription medicines in the United States and New Zealand: an analysis of regulatory approaches and consumer responses" in International Journal of Advertising, Vol. 23, No. 2, pp. 197-227.
16. Hoek, J., Maubach, N. (2005), "A model for addressing stakeholders' concerns about direct-to-consumer advertising of prescription medicines" in European Journal of Marketing, Vol. 39, Nos 9/10, pp. 1151-65.
17. Huh, J., Becker, L.B. (2005), "Direct-to-consumer prescription drug advertising: understanding its consequences" in International Journal of Advertising, Vol. 24, No. 4, pp. 441-66.
18. Huh, J., DeLorme, D.E., Reid, L.N. (2004), "The information utility of DTC prescription drug advertising" in Journalism & Mass Communication Quarterly, Vol. 81, No. 8, pp. 788-806.
19. Joseph, M., Stone, G., Haper, J., Stockwell, E., Johnson, K., Huckaby, J. (2005), "The effect of manufacturer-to-consumer prescription drug advertisements: an exploratory investigation" in Journal of Medical Marketing, Vol. 5, No. 3, pp. 233-44.
20. Jones, S.C., Mullan, J. (2006), "Older adults' perceptions and understanding of direct-to-consumer advertising" in Journal of Consumer Marketing, Vol. 23, No. 1, pp. 6-14.
21. Kaiser Family Foundation (2003), Impact of Direct-to-Consumer Advertising on Prescription Drug Spending, Report #6084, The Henry J. Kaiser Foundation, Washington, DC, available at: http://www.kff.org (accessed January 18, 2008).
22. Lambert, Z.V., Doering, P.L., Goldstein, E., McCormick, W.C. (1980), "Predispositions toward generic drug acceptance" in Journal of Consumer Research, Vol. 7, No. 1, pp. 14-23.
23. Levin, A.A. (2002), "Pharmaceutical industry defends drug advertising", Healthfacts, Center for Medical Consumers, available at: http://findarticles.com/p/articles/mi_m0815/is_2002_Feb/ai_82779474 (accessed January 18, 2008).
24. Lexchin, J., Mintzes, B. (2002), "Direct-to-consumer advertising of prescription drugs" in Journal of Public Policy & Marketing, Vol. 21, No. 2, pp. 194-201.
25. MacKinven, M. (1999), "Pill purveyors go direct" in New Zealand Doctor, March 17, p. 11.
26. Menon, A.M., Deshpande, A.D., Zinkhan, G.M., Perri, M. III (2004), "A model assessing the effectiveness of direct-to-consumer advertising: integration of concepts and measures from marketing and healthcare" in International Journal of Advertising, Vol. 23, No. 1, pp. 91-118.
27. Mintzes, B. (2001), "An assessment of the health systems impacts of direct to consumer advertising of prescription medicines (DTCA)", The University of British Columbia, Centre for Health Services & Policy Research, HPRU 02:2D.
28. Mintzes, B., Barer, M.L., Kravitz, R.L., Kazankian, A., Basset, K., Lexchin, J., Evans, R.G., Pan, R., Marion, S.A. (2002), "Influence of direct to consumer pharmaceutical advertising and patients' requests on prescribing decisions: two site cross sectional survey" in British Medical Journal, Vol. 324, pp. 278-9.
29. National Health Council (2002), "Direct-to-consumer prescription drug advertising: overview and recommendations", available at: www.nationalhealthcouncil.org (accessed on May 20, 2007).
30. National Institute for Health Care Management (2000), "Prescription drugs and mass media advertising", available at: www.nihcm.org (accessed on May 20, 2007).
31. Parker, B.J., Delene, L.M. (1998), "Direct-to-consumer prescription drug advertising: content analysis and public policy implications" in Journal of Pharmaceutical Marketing and Management, Vol. 12, No. 4, pp. 27-59.
32. Petroshius, S.M., Titus, P.A. (1995), "Physician attitudes toward pharmaceutical drug advertising" in Journal of Advertising Research, Vol. 35, No. 6, pp. 41-51.
33. Peyrot, M., Alperstein, N.M., Doran, D.V., Poli, L.G. (1998), "Direct-to-consumer ads can influence behavior" in Marketing Health Services, Vol. 18, No. 2, pp. 27-32.
34. PhRMA (Pharmaceutical Research and Manufacturers of America) (2005), "PhRMA guiding principles: direct to consumer advertisements about prescription medicines", available at: http://www.phrma.org (accessed on May 20, 2007).
35. Roth, M.S. (1994), "Enhancing consumer involvement in health care: the dynamics of control, empowerment, and trust" in Journal of Public Policy & Marketing, Vol. 13, No. 1, pp. 115-32.
36. Sheffet, M.J., Kopp, S.W. (1990), "Advertising prescription drugs to the public: headache or relief?" in Journal of Public Policy & Marketing, Vol. 9, No. 2, pp. 42-61.
37. Shimp, T.A., Dyer, R.F. (1979), "The pain-pill-pleasure model and illicit drug consumption" in Journal of Consumer Research, Vol. 6, No. 1, pp. 36-46.
38. Shin, J., Moon, S. (2005), "Direct-to-consumer prescription drug advertising: concerns and evidence on consumers' benefit" in Journal of Consumer Marketing, Vol. 22, No. 7, pp. 397-403.
39. Spake, D.F., Joseph, M. (2007), "Consumer opinion and effectiveness of direct-to-consumer advertising" in Journal of Consumer Marketing, Vol. 24, No. 5, pp. 283-92.
40. US Census Bureau News (2005), "College degree nearly doubles annual earnings, census bureau reports", available at: www.census.gov/Press-Release/www/releases/archives/education/004214.html (accessed on May 11, 2007).
41. Weissman, J.S., Blumenthal, D., Silk, A.J., Zapert, K., Newman, M., Leitman, R. (2003), "Consumers' reports on the health effects of direct-to-consumer drug advertising" in Health Affairs, Web Exclusive, pp. W3-82-95, available at: http://content.healthaffairs.org/current.shtml (accessed on June 29, 2007).
42. Weissman, J.S., Blumenthal, D., Silk, A.J., Newman, M., Zapert, K., Leitman, R., Feibelmann, S. (2004), "Physicians report on patient encounters involving direct-to-consumer advertising" in Health Affairs, Web Exclusive, pp. W4-219-33, available at: http://content.healthaffairs.org/current.shtml (accessed on June 29, 2007).
43. White, H.J., Draves, L.P., Soong, R., Moore, C. (2004), "'Ask your doctor!' measuring the effect of direct-to-consumer communications in the world's largest healthcare market" in International Journal of Advertising, Vol. 23, No. 1, pp. 53-68.
44. Wilkes, M.S., Bell, R.A., Kravitz, R.L. (2000), "Direct-to-consumer prescription drug advertising: trends, impact, and implications" in Health Affairs, Vol. 19, No. 2, pp. 110-26.